Patent · US Active

Neisseria meningitidis antigens and compositions

US9139621B2 · kind B2 · utility

6Cited by
22References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 23, 2011
Grant dateSep 22, 2015
Priority date
Expiry dateMar 23, 2031

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S530/825
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides proteins from Neisseria meningitidis, including the amino acid sequences and the corresponding nucleotide sequences. The proteins are predicted to be useful antigens for vaccines and/or diagnostics.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.